皮质类固醇治疗和血管并发症在接受过导管大动脉置换的患者中:用元回归进行元分析
Francis Yuri Macedo1, Tilak Pasala1, Ryan Kaple1
1Division of Structural Heart Disease, Department of Medicine, Hackensack University Medical Center, Hackensack, New Jersey.
概括
皮质类固醇在透导管大动脉置换患者的使用增加了血管并发症和出血风险. 然而,这项研究没有发现30天死亡率的增加,这表明需要仔细考虑皮质类固醇治疗.
科学领域:
- 心脏病学 心脏病学
- 血管外科 血管外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮质类固醇与血管脆弱性,伤口愈合延迟和感染有关.
- 过导管大动脉置换 (TAVR) 是对大动脉狭窄的常见手术.
- 皮质类固醇使用对TAVR结果的影响需要进一步调查.
研究的目的:
- 为了比较TAVR患者的血管并发症率,出血事件和死亡率,使用或不使用皮质类固醇.
- 为了确定与皮质类固醇治疗相关的特定血管并发症.
- 分析皮质类固醇使用与TAVR后的二次结果之间的关联.
主要方法:
- 一个研究水平的元分析和观测研究的元回归.
- 主要终点包括大/小血管并发症,危及生命的出血和30天死亡率.
- 二级终点包括急性损伤,环状破裂,心脏吸管和中风.
主要成果:
- 接受皮质类固醇治疗的患者患血管并发症的比率明显更高,主要是动脉封闭,手术,气球血管整形和支架.
- 在使用皮质类固醇的患者中观察到环状断裂和心脏坦波纳的风险增加.
- 两组之间没有发现30天死亡率或皮质类固醇治疗持续时间的显著差异.
结论:
- 在TAVR患者中,皮质类固醇治疗与血管并发症和危及生命的出血风险更高有关.
- 尽管增加了并发症风险,但在这个元分析中,使用皮质类固醇并没有提高30天死亡率.
- 这些发现凸显了对TAVR候选药物中皮质类固醇的谨慎风险益处评估的需要.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
164
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
164
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
147
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
147
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
151
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
151
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406